IMVT logo

Immunovant (IMVT) Selling, General & Administrative Expenses

Annual SGA

$57.28 M
+$9.26 M+19.29%

March 31, 2024


Summary


Performance

IMVT SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIMVTexpensesmetrics:

Quarterly SGA

$19.78 M
+$1.31 M+7.10%

December 31, 2024


Summary


Performance

IMVT Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIMVTexpensesmetrics:

TTM SGA

-$3.89 B
-$382.71 M-10.90%

December 31, 2024


Summary


Performance

IMVT TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIMVTexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

IMVT Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+19.3%+49.7%-7194.6%
3 y3 years+45.0%+71.8%-7999.7%
5 y5 years+215.6%+224.9%-10000.0%

IMVT Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+45.0%at high+71.8%-288.3%at low
5 y5-yearat high+215.6%at high+224.9%-5447.4%at low
alltimeall timeat high+215.6%at high+224.9%<-9999.0%at low

Immunovant Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2024
-
$19.78 M(+7.1%)
$71.88 M(+10.1%)
Sep 2024
-
$18.47 M(-1.8%)
$65.32 M(+7.6%)
Jun 2024
-
$18.81 M(+26.9%)
$60.69 M(+5.9%)
Mar 2024
$57.28 M(+19.3%)
$14.82 M(+12.2%)
$57.28 M(+4.4%)
Dec 2023
-
$13.21 M(-4.5%)
$54.88 M(+2.7%)
Sep 2023
-
$13.84 M(-10.1%)
$53.44 M(+3.8%)
Jun 2023
-
$15.40 M(+24.0%)
$51.47 M(+7.2%)
Mar 2023
$48.02 M
$12.42 M(+5.5%)
$48.02 M(-5.5%)
Dec 2022
-
$11.78 M(-0.8%)
$50.84 M(+0.5%)
Sep 2022
-
$11.88 M(-0.6%)
$50.58 M(-8.0%)
DateAnnualQuarterlyTTM
Jun 2022
-
$11.95 M(-21.6%)
$54.99 M(+1.4%)
Mar 2022
$54.23 M(+37.2%)
$15.24 M(+32.4%)
$54.23 M(+10.0%)
Dec 2021
-
$11.52 M(-29.3%)
$49.29 M(+2.0%)
Sep 2021
-
$16.29 M(+45.7%)
$48.32 M(+17.8%)
Jun 2021
-
$11.18 M(+8.5%)
$41.03 M(+3.8%)
Mar 2021
$39.51 M(+117.7%)
$10.30 M(-2.3%)
$39.51 M(+11.2%)
Dec 2020
-
$10.55 M(+17.2%)
$35.53 M(+14.4%)
Sep 2020
-
$9.00 M(-6.9%)
$31.07 M(+40.8%)
Jun 2020
-
$9.66 M(+53.0%)
$22.07 M(+77.9%)
Mar 2020
$18.15 M
$6.32 M(+3.7%)
$12.40 M(+103.7%)
Dec 2019
-
$6.09 M
$6.09 M

FAQ

  • What is Immunovant annual SGA?
  • What is the all time high annual SGA for Immunovant?
  • What is Immunovant annual SGA year-on-year change?
  • What is Immunovant quarterly SGA?
  • What is the all time high quarterly SGA for Immunovant?
  • What is Immunovant quarterly SGA year-on-year change?
  • What is Immunovant TTM SGA?
  • What is the all time high TTM SGA for Immunovant?
  • What is Immunovant TTM SGA year-on-year change?

What is Immunovant annual SGA?

The current annual SGA of IMVT is $57.28 M

What is the all time high annual SGA for Immunovant?

Immunovant all-time high annual SGA is $57.28 M

What is Immunovant annual SGA year-on-year change?

Over the past year, IMVT annual SGA has changed by +$9.26 M (+19.29%)

What is Immunovant quarterly SGA?

The current quarterly SGA of IMVT is $19.78 M

What is the all time high quarterly SGA for Immunovant?

Immunovant all-time high quarterly SGA is $19.78 M

What is Immunovant quarterly SGA year-on-year change?

Over the past year, IMVT quarterly SGA has changed by +$6.57 M (+49.69%)

What is Immunovant TTM SGA?

The current TTM SGA of IMVT is -$3.89 B

What is the all time high TTM SGA for Immunovant?

Immunovant all-time high TTM SGA is $487.90 K

What is Immunovant TTM SGA year-on-year change?

Over the past year, IMVT TTM SGA has changed by -$3.95 B (-7194.65%)